Now showing items 1-2 of 2
The immunological dilemma: Cellular innate and adaptive immune response versus human acute myeloid leukemia
(Bentham Science Publishers Ltd., 2007)
It is generally accepted that acute myelogenous leukemia (AML) patients are immunocompromized. On the other hand, antileukemic immune reactivity is important for the improved survival of AML patients treated with ...
Intensive chemotherapy for acute myeloid leukemia differentially affects circulating TC1, TH1, TH17 and TREG cells
(BioMed Central, 2010-07-09)
Background Several observations suggest that immunological events early after chemotherapy, possibly during the period of severe treatment-induced cytopenia, are important for antileukemic immune reactivity in acute myeloid ...